Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation.

María Rozman; Mireia Camós; Dolors Colomer; Neus Villamor; Jordi Esteve; Dolors Costa; Ana Carrió; Marta Aymerich; Josep Lluis Aguilar; Alícia Domingo

doi:10.1002/gcc.20022

Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation.

Identifier:nobleid.org/w1/20260515/6CF1D232

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/6CF1D232.svg?ark=w1%2F20260515%2F6CF1D232)](https://nobleid.org/work/w1/20260515/6CF1D232)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation.

Identifier:nobleid.org/w1/20260515/6CF1D232

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/6CF1D232.svg?ark=w1%2F20260515%2F6CF1D232)](https://nobleid.org/work/w1/20260515/6CF1D232)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work